Loading
Latest filing published 01 Sept 2026 for Prostatype Genomics AB, €6,391. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael Häggman appears in our data through filings on Prostatype Genomics AB shares, published by Finansinspektionen. The record holds 2 filings, for trades running from 31 August 2026 to 1 September 2026.
The open-market record consists of 1 sale worth €152, with no purchase.
The record was last updated on 1 September 2026 with a transaction (€6,391) in Prostatype Genomics AB. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations